...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: A bio investor must
1
Mar 04, 2024 01:18PM

Zenith had a nice bump today..Mgmt must have also watched Billions....LOL!

3
Mar 05, 2024 11:24AM
Share
New Message
Please login to post a reply